Nausea was the primary adverse event, occurring in 67% of participants at the highest dose but predominantly mild-to-moderate in severity
FDA-approved uses and indications Repatha injection is approved: For cardiovascular risk reduction, to reduce the risk of major adverse cardiovascular events (MACE) , such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events Along with diet and exercise, to reduce the low-density lipoprotein cholesterol (LDL-C) in: Hypercholesterolemia in adults Heterozygous familial hypercholesterolemia (HeFH) in adults and children 10 years and older Homozygous Familial Hypercholesterolemia (HoFH) in adults and children aged 10 years and older
When you switch medications, the receptor activation profile in your central nervous system changes
How does glutathione injection work
The whole program, not just a prescription